Articles tagged with Human Immunodeficiency Virus
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Experimental drugs show promise against neuroAIDS, a growing concern despite best antivirals. New grant aims to protect brain from HIV-related nerve damage using compounds that counter toxins and reduce inflammation.
Duke University researchers developed a computer model to predict the effectiveness of various microbicidal recipes in destroying HIV before it reaches body tissues. The study found that a thin coating of microbicide delivered to the vagina can significantly reduce HIV transmission.
Research suggests that HIV RNA levels have limited value in predicting CD4 cell count decrease and may not be a reliable marker for disease progression. The study found that only 4-6% of the rate of CD4 cell decline can be explained by presenting plasma HIV RNA level.
Chronic binge drinking in rhesus macaques accelerated SIV disease progression, increasing time to AIDS and viral loads. The study suggests that early treatment is crucial for reducing alcohol use and extending life among HIV-infected individuals.
Researchers argue that Uganda's dramatic decline in HIV rates was partly due to the 'ABC' approach, which included policies to advance women's status. However, critics counter that the approach assumes unrealistic social circumstances for young women, putting them at risk of exploitation and ignorance.
Researchers at Mayo Clinic have discovered that HIV requires a specific human protein, LEDGF/p75, to integrate into the human genome. The study found that disrupting this connection could lead to new therapies for HIV or safer gene therapy methods.
A Swedish HIV vaccine trial has shown that over 90% of subjects developed an immune response to HIV after receiving the vaccine, demonstrating a high level of protection against the virus. The study's results are promising and could lead to further clinical trials in Africa.
Researchers found that the human gut stores a significant amount of HIV, equivalent to nearly twice the amount in the bloodstream. The gut's role in harboring the virus was not fully understood until now.
Researchers from the Université de Montréal have identified a defect in the immune response to HIV and found a way to correct it. The team successfully stimulated a protein that prevents the virus from making immune system cells dysfunctional, opening new prospects for therapeutic strategies.
The International AIDS Society guidelines recommend treating HIV patients with an undetectable viral load using a combination of FUZEON and protease inhibitors. This approach is supported by recent clinical trials and has been endorsed by various health organizations, aiming to combat drug resistance and improve treatment outcomes.
Health development agencies contribute to insufficient public health budgets by requiring host countries to fund interventions sustainably. Public health budgets increase with stronger national and international financial commitments, improving healthcare capacity within host countries.
A massive scale-up of HIV/AIDS treatment programs in Zambia showed favorable patient outcomes, demonstrating the feasibility of expansion in sub-Saharan Africa. The program's success was attributed to leadership and advocacy by the Zambian government, strict protocols for patient care, and large financial resources.
The study found that the efavirenz plus two-NRTI regimen was significantly more effective at reducing HIV viral load in the blood. A second approach, lopinavir/ritonavir, also performed well and may be a viable alternative for patients who experience intolerable side effects from NRTIs. The trial included 753 participants and showed su...
Researchers at Indiana University are working on a project to craft messages that encourage women to be tested for HIV and enroll in research clinical studies. The study aims to identify barriers to testing and develop persuasive messages to overcome them.
A new CD-ROM containing more than 40 selected chapters from the HIV InSite Knowledge Base is being released to provide comprehensive HIV information in the developing world. The disk features a wide range of topics, including natural science, diagnosis and clinical management, transmission and prevention.
A tailored HIV prevention program was found to decrease risky sexual behavior among Latino adolescents, increasing condom use and abstinence. The program incorporated aspects of Latino culture into sexual health education messages, resulting in significant reductions in unprotected sex and multiple partners.
A culturally tailored HIV-prevention program reduces risky sexual behaviors among Latino adolescents, even a year after attendance. The study demonstrates the effectiveness of behavioral training in decreasing HIV transmission risk.
The Heineken Workplace Programme, which provides antiretroviral treatment to employees, shows that offering HAART is feasible. By restricting treatment options, companies can manage HIV patients while prioritizing the health of their workforce.
Stopping HIV treatment temporarily can decrease side effects and expenses, however it might cause the disease to progress faster. Researchers discovered that interrupting treatment for certain periods of time was as effective as continuous therapy in controlling the virus.
A Purdue University researcher has developed a molecule that can effectively combat drug-resistant strains of HIV, the virus that causes AIDS. The FDA recently approved the pill-based therapy, known as Darunavir, which is expected to be available to physicians this year.
Researchers discovered that HIV's surface glycoprotein interacts with CXCR4 on uninfected CD4+ T cells, triggering autophagy. This interaction leads to the death of uninfected bystander cells, contributing to the depletion of immune system cells in AIDS patients.
Dr. Joe Sodroski, a renowned HIV researcher, received the 2006 Retrovirology Prize for his significant contributions to understanding HIV infection and disease. He made key discoveries about how HIV infects cells and causes disease, including identifying the Rev gene and producing the first X-ray structure of gp120.
Global Plan to Stop TB 2006-2015 aims to increase joint TB/HIV programs, benefiting 3 million co-infected with antiretrovirals. Tuberculosis is a leading killer of people living with HIV, and collaboration between communities and governments is crucial to access effective interventions.
The Indian government's plan for controlling HIV is not yet fully implemented, and the consequences could be devastating. Experts call for increased access to care and treatment services, as well as strategic knowledge building, to mitigate the social fallout of the epidemic.
A study of 18 HIV-positive subjects reveals that HIV in the brain and central nervous system is genetically different from HIV in the blood. A particular mutation in the HIV envelope gene is correlated with cognitive impairment, suggesting a key to understanding and potentially treating HIV dementia.
A cross-sectional study of 1,268 adults in Botswana found that routine HIV testing is widely accepted and may reduce barriers to testing. The authors emphasize the importance of informed consent and human rights safeguards to protect individuals from discrimination and violence related to testing.
A study of 38 infant-mother pairs found that women who transmitted HIV to their babies had lower levels of a neutralizing antibody, suggesting its potential as a protective factor. The study suggests further research into the antibody's role could lead to an effective vaccine or passive antibody approaches.
A study found that only 15% of adolescent sexual assault survivors completed the full 28-day course of antiviral medications, highlighting difficulties in prescribing therapies to this population. The lack of adherence is attributed to factors such as unclear risk assessment and psychiatric conditions.
A randomized trial in Zimbabwe found that providing HIV testing at the workplace significantly increases uptake of voluntary counselling and testing. The study suggests that this approach could improve HIV testing rates in Africa, and that intermittent provision might be as effective as continuous testing.
A comprehensive training plan is needed to deliver HIV medicines to patients in poor countries. The authors suggest research is required to define the best approach, including the implementation of such programs.
The University of Pittsburgh-affiliated Magee-Womens Research Institute has been selected to lead international HIV/AIDS prevention and treatment efforts. The institute will focus on developing microbicides to prevent HIV transmission, particularly among women and their partners.
A recent study in Zambia found that abstinence messages were not enough to prevent HIV infection among unmarried women aged 13-20. Women from more conservative denominations abstained longer and had lower rates of condom use during first sex, highlighting the need for targeted prevention strategies.
A new international collaboration aims to identify genetic variations that affect the body's response to HIV. By analyzing patient cohorts from nine countries, researchers hope to pinpoint common genes influencing the disease progression and develop a vaccine targeting these responses.
A study found that HIV-positive mothers-to-be are at a higher risk of developing anaemia, pregnancy-induced hypertension, and other health issues. Women with HIV also received less antenatal care and experienced lower birth weights, highlighting the need for better guidance on managing pregnant women with HIV.
A new study found that HIV infection rates among young non-Hispanic blacks are significantly higher than other racial groups, with a rate of 4.9 per 1,000 compared to 0.22 for all other races. The study suggests that segregation and differences in sexual networks contribute to the disparity.
Advances in HIV care have yielded a total survival benefit of 2.8 million years in the US, saving an additional 137,000 years of life through mother-to-child transmission prevention. The study found that HIV therapies have transformed the disease from a rapidly fatal condition to a controllable one.
The Infectious Diseases Society of America calls for routine HIV testing to identify those who need treatment. Early testing and connection with care can save millions more lives beyond the three million already saved through antiretroviral therapy.
Researchers at FSU have produced high-resolution images of the HIV virus, revealing its complex molecular surface architecture and enabling the development of more effective vaccines. The study, published in Nature, provides valuable insights into the virus's structure and behavior, which could lead to breakthroughs in vaccine design.
A recent study published in AIDS Education and Prevention found that few HIV-positive gay men regret sharing their diagnosis with friends and family. In fact, only 4.2% of participants reported regret after disclosing their status to at least one social network member.
A study found that patients with HIV-HBV coinfection can successfully undergo liver transplantation without progression of viral disease, even in the setting of lamivudine resistance. Controlling HBV is crucial for survival, and ongoing monitoring will be essential to minimize liver-related complications.
A new study will develop a cohort of 1,000 HIV-infected IDUs with a history of injection drug use to examine treatment access and adherence. The research aims to improve access to life-saving HIV and HCV treatments for marginalized individuals in Vancouver's Downtown Eastside.
The US government's PEPFAR program aims to prevent 7 million new HIV infections by 2010, but a GAO report reveals that an ambiguous approach to condom promotion may hinder its success. Promoting condoms alongside abstinence and faithfulness messages is crucial for reaching this target.
A study assessing combined interventions found co-trimoxazole, ART, and insecticide-treated bed nets substantially reduced malaria frequency in HIV-infected adults. The treatments had a cumulative protective effect on malaria incidence, with co-trimoxazole lowering rates by 76%, ART and co-trimoxazole by 92%, and all three by 95%.
Researchers will investigate whether liver damage in HIV patients with hepatitis C is caused by the medication or the virus itself. The goal of the study is to improve treatment outcomes for patients with both conditions.
A new study by Johns Hopkins Medicine researchers suggests that a commercially available antibiotic, ceftriaxone, may be effective in fighting dementia in HIV patients. The study found that ceftriaxone protected human neuronal cells from the effects of HIV proteins Tat and gp120.
A University of Toronto study found HIV infection rates declining in South India, likely due to increased condom use and awareness programs. The study tracked data from antenatal clinics, showing a significant decrease in new infections among young adults.
TB researchers hope to find novel ways of killing the organism using a protective protein called heme oxygenase 1. The project aims to pinpoint the role of alcoholism in the global epidemic by studying HIV- and tuberculosis-infected patients in India.
A study published in Archives of Dermatology found that injecting polylactic acid can safely and effectively treat facial lipoatrophy in HIV patients, improving skin and fat thickness over 12 months. The treatment showed significant results, with increased dermal thickness persisting beyond the initial six injections.
Two DNA repair proteins, XPB and XPD, can destroy HIV DNA, reducing viral replication and integration into host chromosomes. This finding may lead to new strategies for treating HIV infection and AIDS.
Scientists have discovered a way to increase HIV-1 p24 protein production in plants using antibody-antigen fusion molecules, potentially leading to cheaper and more effective vaccines. This technology could also pave the way for mass-producing plant-derived pharmaceuticals for poor populations in developing countries.
A study analyzing healthcare utilization data for HIV-infected patients found that HAART is cost-effective as long as patients stick to treatment. However, the study also revealed significant disparities in healthcare costs between healthier and sicker patients, highlighting inadequate reimbursement to treating physicians and clinics.
Researchers found combined therapy improved survival rates for patients with AIDS-related lymphoma, comparable to non-HIV patients with lymphoma treated with CHOP. For standard-risk ARL patients, 79% achieved complete remission and 50% survived after 47 months.
A study by University of Illinois Chicago found that mothers teaching their daughters about HIV and sexual health can significantly reduce high-risk behavior. The Mother/Daughter HIV Risk Reduction program, which included joint mother/daughter homework assignments and abstinence agreements, was more effective than other interventions.
Researchers found a significant decline in HIV prevalence in some groups, with a 49% drop for women aged 15-24 and a 23% drop for men aged 17-29. Behavioral changes, including delayed sex and fewer casual partners, are believed to be the main reason for this decline.
A Duke University Medical Center study found that free HIV tests are more cost-effective in preventing infections, drawing in three times as many people for testing. The research showed that the cost of prevention dropped from $170 to $92 per person when testing rates increased.
The study found that non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant viruses have an advantage over sensitive viruses even at low levels of adherence. NNRTI and protease inhibitors are potent antiretroviral drugs with demonstrated effectiveness when taken as directed.
Researchers have discovered a novel strategy for enhancing HIV vaccination by silencing the SOCS1 molecule in dendritic cells, which can induce a good memory immune response and boost the potency of HIV DNA vaccination. This approach has potential for therapeutic and prophylactic vaccines against HIV and other pathogens.
A new HIV vaccine strategy involves removing the natural immune system's 'brake' to enhance anti-HIV responses, showing promise for improved treatment and prevention. The approach uses a molecule called SOCS1 to regulate immune cells and boost antibody and T-cell responses.
A study found that adolescent daughters of parents with HIV have a high childbearing rate, with 38-67% experiencing pregnancy. Interventions like family-based counseling and academic support reduced the likelihood of early childbearing.
The Children's Hospital of Philadelphia has received a four-year, $6.7 million grant to study novel HIV therapy targeting neurokinin-1 receptors. The program aims to block the virus from immune cells, improve innate immune function, and reduce symptoms of depression associated with the disease.